Phase 3 data support “changing the current standard of care to now include neoadjuvant and adjuvant pembrolizumab,” according to Ravindra Uppaluri, MD, PhD.

Researchers sought to determine whether dual-targeted CAR-T therapy would be effective for patients with relapsed or refractory MCL.

Neoadjuvant cobolimab and dostarlimab followed by surgery and adjuvant dostarlimab may confer benefits over perioperative pembrolizumab in patients with high-risk, resectable melanoma.

Addition of neoadjuvant and adjuvant pembrolizumab to standard care significantly improves event-free survival.

Colorectal Cancer Screening Scale is a gender-specific instrument developed and validated to assess for barriers to colorectal cancer screening among men.

There was a shorter time between treatments in the preoperative SRT arm. Preoperative stereotactic radiation therapy (SRT) could expedite treatment for cancer patients with brain metastases and is as ...

SAD-CP, a home-based palliative care program, was shown to effectively meet the care needs of patients with advanced cancer, particularly in underserved areas.

Researchers sought to determine whether CD26-positive leukemic stem cell levels could be used as a predictor of outcomes among patients with CML.

Despite the increasing numbers of men seeking careers in nursing, persistent stereotypes and other barriers continue to limit ...

Undergoing sentinel lymph node biopsy and radical hysterectomy without pelvic lymphadenectomy may reduce the risk of retroperitoneal nodal recurrence and cancer-specific death.

HealthDay News — For women with breast cancer (BC), BRCA mutations are associated with increased risk of developing breast implant–associated anaplastic large cell lymphoma (BIA-ALCL), according to a ...

Pembrolizumab, an anti-programmed death receptor-1 (PD-1) therapy, is currently approved under the brand name Keytruda ® for other gynecological cancers, including cervical cancer and endometrial ...